Last reviewed · How we verify
NCT05941143
Effect of Mindfulness on EEG Brain Activity for Cognitive and Psychological Well-being in the Elderly
NA trial testing mindfulness-based intervention in Healthy Aging in 77 participants. Completed in 15 December 2021.
15 December 2021
Quick facts
| Lead sponsor | IRCCS Centro San Giovanni di Dio Fatebenefratelli |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 77 |
| Start date | 11 September 2019 |
| Primary completion | 15 December 2021 |
| Estimated completion | 15 December 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- mindfulness-based intervention
Conditions studied
- Healthy Aging — all drugs for Healthy Aging →
Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Who can join
Adults 60 to 75, any sex, with Healthy Aging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
As the worldwide population of older adults rapidly increases over the coming years, effective strategies are needed to help this population to maintain and enhance physical, cognitive, and psychological well-being. Up to 10% of community dwelling older adults have depressive symptoms in Europe. Older adults are also subject to chronic illnesses which further exacerbate psychological symptoms. Furthermore, normal aging is associated with decline in cognitive functioning. Given the prevalence of mental health problems and cognitive difficulties in older adults, mindfulness-based interventions (MBIs) could be helpful in this population. Accordingly, a growing number of studies suggest that mindfulness-based interventions in the elderly have beneficial effects on psychological health (decrease in depression, anxiety, sleep problems, and increase in general mood and positive affect) and cognition (enhanced attention, executive functions). Electroencephalography (EEG) is a non-invasive technique which can be useful to study the neurophysiological correlates of mindfulness, and give neurobiological evidence of its beneficial effect in the elderly. Studies that examined spectral power outcomes between mindfulness and control state showed (i) increased alpha and theta power, as a marker of internally-directed attention processing and executive functioning and (ii) a shift towards left-sided anterior alpha activation, a pattern associated previously with positive emotions. The aim of this study is to evaluate short and long-term cognitive, psychological, and physiological effects of a standard 8-week MBI in healthy older adults. Cognitive and psychological evaluations, and resting state EEG will be administered within 2 weeks prior to and within 2 weeks following MBI, and repeated 24 weeks following MBI.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cognitive, psychological, and physiological effects of a web-based mindfulness intervention in older adults during the COVID-19 pandemic: an open study.
Galluzzi S, Lanfredi M, Moretti DV, Rossi R, et al · · 2024 · cited 6× · PMID 38350854 · DOI 10.1186/s12877-024-04766-z
Verify or expand the search:
- PubMed search for NCT05941143
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of mindfulness-based intervention
Trials testing the same drug.
- NCT06298136 — The Effects of an Online Mindfulness-based Intervention for Children with Attention-Deficit/Hyperactivity Disorder · NA · recruiting
- NCT06021236 — Efficacy of a Mindfulness-Based Intervention in Patients With Cardiovascular Implantable Electronic Device · NA · terminated
Other recruiting trials for Healthy Aging
Currently open trials in the same condition.
- NCT07515495 — Effectiveness of Intensive Tutoring vs. Flexible Self-Learning on Digital Health Literacy and Self-Efficacy for "My Heal · NA · recruiting
- NCT07231783 — The Effect of Urolithin A (Mitopure®) Supplementation on Muscle Strength in Healthy Middle-Aged Adults · NA · recruiting
- NCT07308353 — Comparative Effects Of Exergaming And Otago Exercise On Anticipatory Postural Control And Sensory Integration In Older A · NA · active not recruiting
- NCT07207044 — FAXAGE: Fasting And Exercise To Slow Aging In Humans · NA · recruiting
- NCT07151365 — Plant-based Diets and Healthy Aging · recruiting
Other IRCCS Centro San Giovanni di Dio Fatebenefratelli trials
Trials by the same sponsor.
- NCT07497347 — Effects of Specific Amino Acid Supplementation and Lifestyle Factors on Brain Ageing · NA · recruiting
- NCT06914622 — Real-time Experiences, Physical Activity and Biological Outcomes in Personal Recovery Residents (EMPOWER-RES) · NA · recruiting
- NCT06989944 — Physical Activity-based Intervention in Depressed Patients: Clinical, Neurophysiological, Epigenetic and Metabolic Corre · NA · active not recruiting
- NCT06657274 — EARLY-COGN^3 - Smart Digital Solutions for EARLY Treatment of COGnitive Disability: a Neuropsychological, Neurophysiolog · NA · recruiting
- NCT06461104 — Physical Activity in People With Borderline Personality Disorder (PABORD) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05941143 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Centro San Giovanni di Dio Fatebenefratelli
- Last refreshed: 12 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05941143.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing